Javon Bea President and CEO; Mercy Health System Named as Working Mother 100 Best Company

Monday, October 1st, 2012


Janesville, WI (PRWEB) September 26, 2012

Mercy Health System, Javon Bea President and CEO: Working Mother magazine today announced Mercy Health System as one of its 2012 Working Mother 100 Best Companies. Working Mother rewarded companies based on the wide array of progressive workplace programs, including child care, flexibility, advancement and paid family leave. In addition, Mercy is named a Top 10 Best Company for Health and Wellness.

“We are very honored to be listed among the best companies for working mothers,” says Javon R. Bea, president and CEO of Mercy Health System. “Working mothers continue to make valuable contributions in all areas of Mercy Health System. It’s both our pleasure and responsibility to ensure that we create a supportive and flexible work environment that enable them to succeed.”

To recognize Mercy’s continuous leadership as a best company for working women, Mercy asked its employees (called partners) to nominate themselves or a fellow Mercy mom to be deemed Mercy’s Working Mother of the Year by submitting an essay; the essays showcased how Mercy has helped contribute to the partner’s work/life balance, allowing moms to be successful at balancing it all: a successful career, a loving family and time for themselves. After careful review of over 40 finalists, one winner was chosen, Nina Graham, RN, at Mercy Hospital and Trauma Center.

Mercy will be recognized in the October/November issue of Working Mother magazine, on WorkingMother.com and will be honored at the Work Life Congress in New York City, October 8.

To read why Nina was chosen, visit MercyBlogs.org and click on “partner and patient stories.” For more information about Mercy Health System, visit MercyHealthSystem.org.

Founded in 1895, Mercy Health System is a not-for-profit, vertically integrated multi-specialty health system that serves more than one million individuals through its 68 facilities in 26 southern Wisconsin and northern Illinois communities. Since 1989, Mercy Health System has grown from a stand-alone community hospital with no employed physicians and no ambulatory care centers into a comprehensive, vertically integrated health system offering an extensive network of primary and specialty care physicians, three hospitals, subspecialty centers of excellence, insurance products, long term care, retail services, and preventive health and wellness programs. Mercy employs over 400 physicians and nearly 4,000 employees, who are called partners. Mercy Health System is headquartered in Janesville, Wisconsin. Javon Bea is the President and CEO of Mercy.

Working Mother Media, a division of Bonnier Corporation, publishes Working Mother magazine and its companion website, WorkingMother.com, and the Working Mother Research Institute. The National Association for Female Executives (nafe.com), Diversity Best Practices (diversitybestpractices.com) are also units within WMM. Working Mother Media’s mission is to serve as a champion of culture change. Working Mother magazine reaches more than 2 million readers and is the only national magazine for career-committed mothers; WorkingMother.com gives working mothers @home and @work advice, solutions, and ideas. This year marks the 27th anniversary of the magazine’s signature research initiative, Working Mother 100 Best Companies, and the 10th year of the Best Companies for Multicultural Women.







Alonso Krangle LLP Files Fosamax Lawsuit on Behalf of a Woman who Suffered Right Femur Fracture, Allegedly as a Result of Her Use of Fosamax

Sunday, September 30th, 2012


Melville, New York (PRWEB) September 25, 2012

Alonso Krangle LLP, a national law firm and NY personal injury firm focused on fighting for the rights of serious personal injury victims of harmful drug side effects, announce they have filed a Fosamax lawsuit on behalf of a woman who suffered a fracture of her right femur, allegedly as a result of her use of Fosamax. The Fosamax femur fracture lawsuit, which was filed on September 12, 2012 in New Jersey Superior Court, Atlantic County, names Merck Sharp & Dohme Corp. f/k/a Merck & Company, Inc. as Defendant (Case No. ATL-L-006286-12).

Alonso Krangle is currently offering FREE Fosamax lawsuit consultations to anyone who suffered a femur fracture that may be related to their use of Fosamax. To discuss a potential claim with one of the experienced and compassionate Fosamax femur fracture lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, FightForVictims.com.

According to the new Fosamax femur fracture lawsuit filed by Alonso Krangle, the Plaintiff, a woman from Castle Pines, Colorado, suffered a right femur fracture on November 16, 2011, allegedly due to Fosamax. The complaint notes that over the past few years, there have been an increasing number of reports of patients suffering stress factures as a result of severely suppressed bone turnover caused by long-term Fosamax use. The complaint further alleges that the Defendants knew of the significant risk of severely suppressed bone turnover, brittle bones, and multiple stress fractures associated with long-term use of Fosamax, but did not sufficiently warn consumers, the Plaintiff, her doctors or the medical community. Because of her use of Fosamax, the complaint alleges the Plaintiff suffered severe medical pain and suffering, and has and will sustain permanent injuries and emotional distress, along with economic losses due to medical expenses, and living-related expenses due to her new life style. The complaint further alleges that she would not have used Fosamax had the Defendants properly disclosed the risks or side effects associated with its long-term use.

Fosamax, marketed by Merck & Co., is approved to treat osteoporosis and other bone weakening diseases. In October 2010, the U.S. Food & Drug Administration (FDA) ordered the makers of Fosamax and other bisphosphonates to add information about the risk of atypical femur fractures to the ?Warnings and Precautions? section of their labels. The FDA ordered the label change after a study involving over 300 women who sustained such fractures found that 94 percent had taken a bisphosphonate. Most had been on the drugs for five years or more. [fda.gov/Drugs/DrugSafety/ucm229009.htm]

Since the FDA ordered the label change, more evidence has emerged linking long-term use of Fosamax to an increased risk of femur fractures. In May, an analysis published in the New England Journal of Medicine (NEJM) by FDA researchers found little benefit from the long-term use of bisphosphonates (longer than five years). According to the study, long-term use of Fosamax and similar drugs has raised questions because of their potential association with serious side effects, including atypical thigh fractures, Osteonecrosis of the Jaw (ONJ or Dead Jaw Syndrome), and esophageal cancer. [nejm.org/doi/full/10.1056/NEJMp1202619]

In June, a study published in the Archives of Internal Medicine reported that the likelihood that a patient will experience an atypical femur fracture increases the longer they use bisphosphonates like Fosamax. According to the report, 82 percent of the patients with atypical fractures had been treated with bisphosphonates, like Fosamax, compared with about 6 percent of the patients with classic fractures.

[archinte.jamanetwork.com/article.aspx?doi=10.1001/archinternmed.2012.1827]

Hundreds of women throughout the country have filed Fosamax femur fracture lawsuits seeking compensation for their pain and suffering. Many of those complaints have been consolidated in a Mass Tort proceeding (In re: Fosamax Litigation – No. 282 NJ. Super. Ct.) in the Superior Court of New Jersey, Law Division, Atlantic County. Hundreds of other Fosamax lawsuits are pending in a multidistrict litigation in U.S. District Court, District of New Jersey before the Honorable Garrett E. Brown, Jr. (?MDL No. 2243).

Alonso Krangle LLP offers free lawsuit evaluations to any Fosamax user who suffered a femur fracture that could be associated with long-term use of this drug. To discuss a potential claim with one of the experienced and compassionate Fosamax femur fracture lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, FightForVictims.com.

About Alonso Krangle LLP

Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and New Jersey.

For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact:

Alonso Krangle LLP

445 Broad Hollow Road

Suite 205

Melville, New York 11747

Toll-FREE 1-800-403-6191

Tel: 516-350-5555

Fax: 516-350-5554







Avery Healthcare Care Homes

Saturday, September 29th, 2012

John Strowbridge introduces Avery Healthcare’s latest care home and explains the company’s approach to care for the elderly.